Here’s Who Just Picked Up Social Reality Inc. (NASDAQ:SRAX) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Social Reality Inc. (NASDAQ:SRAX) reported that Runnels G Tyler has picked up 412,784 of common stock as of 2017-03-30.
The acquisition brings the aggregate amount owned by Runnels G Tyler to a total of 412,784 representing a 5.29% stake in the company.
For those not familiar with the company, Social Reality, Inc. is an Internet advertising and platform technology company. The Company provides tools to automate the digital advertising market. It is engaged in the sales of digital media advertising campaigns to advertising agencies and brands; sales of media inventory through real-time bidding (RTB) exchanges; sale and licensing of its SRAX Social platform and related media, and creation of custom platforms for buying media on SRAX for various brands. Its technology assists publishers in delivering their media inventory to the RTB exchanges. It provides the SRAX platform to brands and their advertising agencies. SRAX Social is a social media and loyalty platform that allows brands to launch and manage their social media initiatives. SRAX MD is an advertisement targeting and data platform for healthcare brands and medical content publishers. SRAX APP is a platform that allows publishers and content owners to launch native mobile applications through its SRAX platform.
A glance at Social Reality Inc. (NASDAQ:SRAX)’s key stats reveals a current market capitalization of 19.53 Million based on 6.66 Million shares outstanding and a price at last close of $2.45 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-11-21, Hannan picked up 1,250 at a purchase price of $6.24. This brings their total holding to 3,750 as of the date of the filing.
On the sell side, the most recent transaction saw Sumichrast unload 8,929 shares at a sale price of $1.25. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Social Reality Inc. (NASDAQ:SRAX) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
22nd Century Group Inc (NYSEMKT:XXII) Shares Up 12.5%
22nd Century Group Inc (NYSEMKT:XXII) shares rose 12.5% on Thursday to $1.20 and were unchanged in after-hours trading. Share prices have been trading in a 52-week trading range of $0.73 to $1.71. The company has a market cap of $107.83 million at 90.70 million shares outstanding.
22nd Century Group Inc is a plant biotechnology company that is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding.
It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.
In a press release, 22nd Century Group Inc announced that representatives of the company’s wholly-owned subsidiary, Botanical Genetics, have been invited to serve as featured speakers and presenters at the annual Colorado Hemp Expo. This will be held at the Ranch Events Complex, 5260 Arena Circle, Loveland, Colorado on Friday, March 31, 2017, and Saturday, April 1, 2017.
We are developing several exciting new strains of medical marijuana as well as industrial hemp varieties with substantially altered levels of cannabinoids – all of which will be below the legal limit of 0.3% THC,” explained Dr. Paul Rushton, Vice President of Plant Biotechnology. “Following our recently announced success with Zero-THC hemp plants and our major collaboration with the University of Virginia, Botanical Genetics is now aggressively expanding our activities in an effort to make our Company a major source of proprietary plants for both the legal medical marijuana and industrial hemp markets. We look forward to exploring exciting business opportunities with like-minded companies in Colorado.”
Along with Thomas James Esq., Vice President & General Counsel, they will provide conference attendees with business and scientific updates and highlights of 22nd Century Group Inc advances in the rapidly evolving legal medical marijuana and industrial hemp markets. This includes Dr. Rushton’s featured speech on Friday evening regarding the 22nd Century Group Inc proprietary cannabis initiatives like their recently announced development of THC-free industrial hemp plants and the propagation of medical marijuana strains that are selected for increased levels of medically-important cannabinoids.
Dr. Rushton will also speak in a panel discussion on Seeds, Clones, Pesticides and Pollen while James will speak on three panel discussions: Investments in Hemp, Global Hemp Activities, and The Future of Hemp. They will also be available for one-on-one discussions.
DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.
Here’s Who Just Picked Up Depomed Inc. (NASDAQ:DEPO) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Depomed Inc. (NASDAQ:DEPO) reported that Starboard Value LP has picked up 5,490,000 of common stock as of 2017-03-30.
The acquisition brings the aggregate amount owned by Starboard Value LP to a total of 5,490,000 representing a 8.8% stake in the company.
For those not familiar with the company, Depomed, Inc. is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER (tapentadol extended release tablets), NUCYNTA IR (NUCYNTA) (tapentadol), Gralise (gabapentin), CAMBIA (diclofenac potassium for oral solution), Zipsor (diclofenac potassium) and Lazanda (fentanyl). Its NUCYNTA ER (tapentadol extended release tablets) is a product for the management of pain severe enough to require daily long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy in adults, and its NUCYNTA (tapentadol) is a product for the management of moderate to severe acute pain in adults. Its Gralise (gabapentin) is a once-daily product for the management of postherpetic neuralgia. Its CAMBIA (diclofenac potassium for oral solution) is a product for the acute treatment of migraine attacks.
A glance at Depomed Inc. (NASDAQ:DEPO)’s key stats reveals a current market capitalization of 771.50 Million based on 62.10 Million shares outstanding and a price at last close of $12.82 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2013-05-10, Schoeneck picked up 25,000 at a purchase price of $5.11. This brings their total holding to 85,001 as of the date of the filing.
On the sell side, the most recent transaction saw Moretti unload 5,000 shares at a sale price of $20.84. This brings their total holding to 21,680.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Depomed Inc. (NASDAQ:DEPO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Foresight Energy Lp (NYSE:FELP) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Foresight Energy Lp (NYSE:FELP) reported that Cline Christopher has picked up 20,552,766 of common stock as of 2017-03-30.
The acquisition brings the aggregate amount owned by Cline Christopher to a total of 20,552,766 representing a 27.1% stake in the company.
For those not familiar with the company, Foresight Energy LP is engaged in the mining and marketing of coal from reserves and operations located in the Illinois Basin. The Company controls over three billion tons of coal in the state of Illinois. Its reserves consist principally of over three contiguous blocks of high heat content (high Btu) thermal coal, which are used for longwall operations. Thermal coal is used by power plants and industrial steam boilers to produce electricity or process steam. The Company operates over four underground mining complexes in the Illinois Basin, including Williamson, which is located in southern Illinois near the town of Marion; Sugar Camp, which is located in southern Illinois approximately 10 miles north of Williamson; Hillsboro, which is located in central Illinois near the town of Hillsboro, and Macoupin, which is located in central Illinois near the town of Carlinville. Williamson, Sugar Camp and Hillsboro are longwall operations, and Macoupin is a continuous miner operation.
A glance at Foresight Energy Lp (NYSE:FELP)’s key stats reveals a current market capitalization of 844.43 Million based on 131.06 Million shares outstanding and a price at last close of $6.54 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-15, Cline picked up 23,197 at a purchase price of $6.74. This brings their total holding to 19,089,218 as of the date of the filing.
On the sell side, the most recent transaction saw Accipiter unload 200,000 shares at a sale price of $7.21. This brings their total holding to 2,823,351.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Foresight Energy Lp (NYSE:FELP) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Americas Carmart Inc. (NASDAQ:CRMT) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Americas Carmart Inc. (NASDAQ:CRMT) reported that Magnolia Capital Fund, Lp has picked up 426,421 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by Magnolia Capital Fund, Lp to a total of 426,421 representing less than 5.5% stake in the company.
For those not familiar with the company, America’s Car-Mart, Inc. is an automotive retailer focused on the integrated auto sales and finance segment of the used car market. The Company conducts its operations through its two operating subsidiaries, America’s Car Mart, Inc. (Car-Mart of Arkansas) and Colonial Auto Finance, Inc. (Colonial) (Collectively, Car-Mart of Arkansas and Colonial are referred to as Car-Mart). It primarily sells older model used vehicles and provides financing for all of its customers. As of April 30, 2016, the Company operated 143 dealerships located primarily in small cities throughout the South-Central United States. Dealerships are operated on a decentralized basis. Each dealership is responsible for buying (with the assistance of a corporate office buyer) and selling vehicles, making credit decisions, and servicing and collecting the installment contracts it originates. Dealerships also maintain their own records and make daily deposits. The Company has both regular and satellite dealerships.
A glance at Americas Carmart Inc. (NASDAQ:CRMT)’s key stats reveals a current market capitalization of 267.91 Million based on 7.80 Million shares outstanding and a price at last close of $35.05 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-05-24, Von picked up 2,000 at a purchase price of $21.33. This brings their total holding to 10,000 as of the date of the filing.
On the sell side, the most recent transaction saw Henderson unload 10,000 shares at a sale price of $41.65. This brings their total holding to 76,984.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Americas Carmart Inc. (NASDAQ:CRMT) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Broadfin Capital Picked Up Alphatec Holdings Inc. (NASDAQ:ATEC) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Alphatec Holdings Inc. (NASDAQ:ATEC) reported that has picked up 1,164,618 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by Broadfin Capital to a total of 1,164,618 representing less than 9.99% stake in the company.
For those not familiar with the company, Alphatec Holdings, Inc. is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. Its products include Cervical and Cervico-Thoracic Products, which include Trestle Luxe Anterior Cervical Plate System and Pegasus Anchored Cervical Interbody; Thoracolumbar Fixation Products, which include Arsenal Degenerative System and OsseoScrew Spinal Fixation System; Spinal Spacers, which include Battalion Universal Spacer System and Alphatec Solus Locking ALIF Spinal Spacer; minimally invasive surgery Products, which include Illico Minimally Invasive Surgery System and BridgePoint Spinous Process Fixation System, and Biologics, which include Neocore Osteoconductive Matrix.
A glance at Alphatec Holdings Inc. (NASDAQ:ATEC)’s key stats reveals a current market capitalization of 21.89 Million based on 8.81 Million shares outstanding and a price at last close of $2.40 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-16, Cross picked up 15,000 at a purchase price of $4.25. This brings their total holding to 65,443 as of the date of the filing.
On the sell side, the most recent transaction saw Foster unload 1,033 shares at a sale price of $5.25. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Alphatec Holdings Inc. (NASDAQ:ATEC) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
5am Ventures Llc. is Buying Pulmatrix Inc. (NASDAQ:PULM) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Pulmatrix Inc. (NASDAQ:PULM) reported that 5am Ventures Llc. has picked up 251,188 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by 5am Ventures Llc. to a total of 251,188 representing less than 1.41% stake in the company.
For those not familiar with the company, Pulmatrix, Inc. is a clinical stage biopharmaceutical company developing inhaled therapies to address serious pulmonary disease. The Company’s product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with lung disease, including cystic fibrosis. In addition, the Company focuses on pulmonary diseases through collaboration with partners, including PUR0200, a generic in clinical development for chronic obstructive pulmonary disease.
A glance at Pulmatrix Inc. (NASDAQ:PULM)’s key stats reveals a current market capitalization of 53.11 Million based on 17.83 Million shares outstanding and a price at last close of $3.23 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-06-15, Mcguire picked up 1,392 at a purchase price of $6.88. This brings their total holding to 52,722 as of the date of the filing.
On the sell side, the most recent transaction saw Oculus unload 922,500 shares at a sale price of $2.75. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Pulmatrix Inc. (NASDAQ:PULM) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Up Si Financial Group Inc. (NASDAQ:SIFI) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Si Financial Group Inc. (NASDAQ:SIFI) reported that Clover Partners, L.p. has picked up 617,773 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by Clover Partners, L.p. to a total of 617,773 representing less than 5.1% stake in the company.
For those not familiar with the company, SI Financial Group, Inc. is a holding company for Savings Institute Bank and Trust Company (the Bank). The Bank operates as a community-oriented financial institution offering a range of financial services to consumers and businesses in its market area, including insurance, trust and investment services. The Bank accepts deposits from the general public and uses those funds to originate one- to four-family residential mortgage loans, multi-family and commercial real estate loans, commercial business loans, and construction and consumer loans. The Bank also purchases commercial business loans, including loans fully guaranteed by the Small Business Administration (SBA) and the United States Department of Agriculture (USDA). The Bank sells certain fixed-rate one- to four-family residential conforming loans it originates in the secondary market with the servicing retained. The remainder of the Bank’s loan portfolio is originated for investment.
A glance at Si Financial Group Inc. (NASDAQ:SIFI)’s key stats reveals a current market capitalization of 164.17 Million based on 12.20 Million shares outstanding and a price at last close of $13.55 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2014-12-08, Engle picked up 500 at a purchase price of $11.22. This brings their total holding to 9,907 as of the date of the filing.
On the sell side, the most recent transaction saw Gervais unload 5,379 shares at a sale price of $11.26. This brings their total holding to 14,657.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Si Financial Group Inc. (NASDAQ:SIFI) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.